Insurers be warned: Many corporate executives are mulling whether they can provide their employees with higher-quality and more cost-effective healthcare without going through an insurance company.
As predi cted, the American M edical Association issued recommendations for Medicare to cover end-of-life discussions with patients, a change that could prompt physicians to initiate these conversations more often, according to an arti cle from the New York Times.
Physicians increasingly explore new practice models to ease their financial strain and restore their satisfaction in medicine, but the process of actually making the switch (or starting a new practice) requires careful planning. A recent article from Medical Economics provided three key successful transition steps
The 10 largest publicly traded insurers paid their top executives a combined $300 million in compensation last year. But because of a little-discussed provision in the Affordable Care Act, they also had to pay $72 million more than the year before in taxes, amounting to an additional $1.3 million in taxes per executive, according to a new report from the Institute for Policy Studies.
Price transparency is more than just an exercise in being up-front--it's imperative to improve the bottom line for any health insurer, says a new report from Families USA.
Health plans participating in health insurance exchanges have a world of hurt coming if they fail to prepare for a complicated and changing regulatory environment--complete with tough enforcement action, a new Deloitte paper says.
State insurance marketplaces need to improve functionality and transparency, says a new report from the Urban Institute and the Robert Wood Johnson Foundation.
California is a brewing hotbed of potential trouble when it comes to insurance rates. California lawmakers propose a state-wide vote on a new ballot initiative that would expand the state's authority to regulate health insurance rates. To make matters worse, voters show signs they support the measure, according to an article in Kaiser Health News.
Medicaid insurers are struggling to pay for pricey drugs, leading some to request states to increase payments so they can run their plans. Meanwhile, some states are deciding restrict the expensive medications.
Over the years, insurers have tried--with varying degrees of success--to rein in prices and moderate the costs of prescription drugs. But to ensure consumers can afford speciality tier drugs, a new issue brief from the Robert Wood Johnson foundation recommends payers team up with state and federal regulators to combat the soaring prices.